Author

Keng-Chang Tsai

Observed name: Tsai, Keng-Chang

Institutions: National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taipei Medical University

Observed institutions: Taichung Veterans General Hospital, National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taipei Medical University

ORCID: 0000-0001-8277-9174

Observed ORCID: 0000-0001-8277-9174

OpenAlex ID: A5074353978

Curbing COVID-19 progression and mortality with traditional Chinese medicine among hospitalized patients with COVID-19: A propensity score-matched analysis

2022 · Yu-Hwei Tseng, Sunny Jui-Shan Lin, et al. · Pharmacological Research · 49

Targeting spike protein-induced TLR/NET axis by COVID-19 therapeutic NRICM102 ameliorates pulmonary embolism and fibrosis

2022 · Wen-Chi Wei, Chia-Ching Liaw, et al. · Pharmacological Research · 29

NRICM101 ameliorates SARS-CoV-2–S1-induced pulmonary injury in K18-hACE2 mice model

2023 · Wen-Chi Wei, Keng-Chang Tsai, et al. · Frontiers in Pharmacology · 10

NRICM101 in combatting COVID-19 induced brain fog: Neuroprotective effects and neurovascular integrity preservation in hACE2 mice

2024 · Cher-Chia Chang, Yea-Hwey Wang, et al. · Journal of Traditional and Complementary Medicine · 6

Synergistic protective effects of TCM formula NRICM102 and N-acetylcysteine against hepatorenal injury in a mouse model of bongkrekic acid poisoning

2025 · Yuh-Chiang Shen, Yea-Hwey Wang, et al. · Frontiers in Pharmacology · 3

Toxicological assessment of novel Anti-COVID traditional Chinese medicine formulae NRICM101 and NRICM102: a comprehensive study on safety and genotoxicity

2025 · Chun-Tang Chiou, Chao-Lin Chang, et al. · Frontiers in Pharmacology · 2

NRICM102, a TCM Formula, Attenuates COPD-Relevant Inflammatory Lung Injury in Mice by Improving Pulmonary Function and Reversing Immune Dysregulation

2026 · Yuh-Chiang Shen, Kuo-Tong Liou, et al. · Pharmaceuticals · 1

Soluble N-terminal EphA2 fragment as a diagnostic biomarker and functional mediator of tumor progression in triple-negative breast cancer

2026 · Tsai-Yu Lin, Fu-Ling Chang, et al. · Translational Oncology

Single chain antibody fragments with serine protease inhibitory property capable of neutralizing toxicity of Trimeresurus mucrosquamatus venom

2014 · 楊沂淵, Yang, Yi-Yuan, et al. · Taipei Medical University Repository

Works count: 9

Citation count: 100

H-index: 4

I10-index: 3